Skip to content

eConsent for kidney biopsy: impact on the patient experience

The patient experience of kidney biopsy: A randomised controlled trial evaluating video-assisted consent versus standard consent for percutaneous ultrasound-guided kidney biopsy in adults

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12621000768897
Acronym
N/A
Enrollment
54
Registered
2021-06-21
Start date
2021-07-21
Completion date
2023-05-08
Last updated
2022-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Informed medical consent is how clinicians communicate important information to patients about procedures/treatments they are recommending. The process of communication is highly individualised, time consuming and at a pace that is usually set by the healthcare worker. It is therefore not surprising that patients report variable and inconsistent comprehension and understanding of clinicians’ explanations of procedures/treatments. The literature demonstrates that audiovisual consent, when used to supplement current methods, improves the patient experience, including higher satisfaction, better comprehension and less anxiety. We will, for the first time in the procedure of kidney biopsies, evaluate patient reported benefits of video-assisted electronic consent compared to a conventional consent process, that being a clinician consenting the patient.

Interventions

Participants in the video-assisted (intervention) group will watch a 6 minute audiovisual consent animation describing the procedure of percutaneous kidney biopsy. This will be shown prior to the participant's consultation with their doctor. Content of the animation video is based on the recently published national CARI guidelines and its translation into the kidney biopsy pathway, approved by the RBWH Forms Review Committee. The final video is structured into 10 sections: “reasons for kidney b

Participants in the video-assisted (intervention) group will watch a 6 minute audiovisual consent animation describing the procedure of percutaneous kidney biopsy. This will be shown prior to the participant's consultation with their doctor. Content of the animation video is based on the recently published national CARI guidelines and its translation into the kidney biopsy pathway, approved by the RBWH Forms Review Committee. The final video is structured into 10 sections: “reasons for kidney biopsy”, “preparing for kidney biopsy”, “the procedure”, “post-procedure”, “benefits”, “risks of not having a kidney biopsy”, “alternatives”, “risks of kidney biopsy”, “patients at increased risk of complications” and “conclusion”. The audio narrative steps the participant through what is displayed in the video. The visual content is augmented by written subtitles and captions.The patient-centric animation was developed in English and will be translated into five other commonly spoken languages (Vietnamese, Arabic, Mandarin, Cantonese and Spanish).

Sponsors

Pedro Henrique Franca Gois
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

All consecutive patients scheduled to undergo a percutaneous kidney biopsy will receive information about the study and be invited to participate. Those that agree will be required to sign written informed consent to proceed into the study.

Exclusion criteria

< 18 years of age. Individuals not competent to consent or refuse to consent to medical treatment. Legally blindness (defined as having corrected acuity of no better than 6/60 and/or a vision field of no more than 10 degrees).

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026